Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Licensing pipeline
Lanosterol 14-alpha demethylase
—
- Therapy
- Infectious Diseases
- Status
- Candidate licensing (UB202)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
TROP2 BsAb + Dual-payload
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB191)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
B7H3 Bi-functional+ Dual-payload
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB190)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
B7H3 BsAb + Dual-payload
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB189)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
PD1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB187)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
EGFR
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB186)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Ion channel inhibitor
—
- Therapy
- Nephrology & Urology
- Status
- Candidate licensing (UB183)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Ion channel inhibitor
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB182)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GPCR
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB181)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GPCR
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB180)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GPCR
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB179)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
KV1.3 (Topical)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB178)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
KV1.3 (Oral)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB177)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, Australia
Licensing pipeline
KV1.3 (Topical)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB176)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, China
Licensing pipeline
Aβ
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB149)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Japan
Licensing pipeline
Androgen receptor
—
- Therapy
- Dermatology
- Status
- Candidate licensing (UB148)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Keratin; Plasmin
—
- Therapy
- Dermatology
- Status
- Candidate licensing (UB147)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ApoC3 (siRNA)
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB146)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Factor XI (siRNA)
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB145)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
(siRNA)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB144)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
PCSK9 (siRNA)
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB140)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
PCSK9 (siRNA)
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB139)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Undisclosed (BsAb+Dual-payload)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB138)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Undisclosed (mAb+Dual-payload)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB137)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
BsAb + Dual-payload
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB136)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
EGFR; cMet
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB127)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
ADAM9
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB126)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
GABAA Receptor
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB125)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1 (Oromucosal)
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB104)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
(iPSC)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB103)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
EBV
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB102)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
HPV
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB101)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
HBV
—
- Therapy
- Gastroenterology & Hepatology
- Status
- Candidate licensing (UB100)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
HBV
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB099)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
HBV
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB098)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- SG
Licensing pipeline
(siRNA)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB097)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
SGLT2 (siRNA)
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB096)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
(siRNA)
—
- Therapy
- Nephrology & Urology
- Status
- Candidate licensing (UB095)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
FcRn (siRNA)
—
- Therapy
- Others > Critical Care
- Status
- Candidate licensing (UB094)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Renin / AGT
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB093)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
(siRNA)
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB092)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Glucosylceramide synthase (siRNA)
—
- Therapy
- Others > Rare Diseases
- Status
- Candidate licensing (UB091)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Calcineurin/Fn14 (siRNA)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB090)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IL4R (siRNA)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB089)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
(Oncolytic virus)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB085)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
(Oncolytic virus)
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB084)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
F protein (RSV)
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB083)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
F protein (RSV)
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB082)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China